Peptides of human immunodeficiency virus type 1 (HIV-1)
US6261564A · kind A · utility
3Cited by
6References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 31, 1997 |
| Grant date | Jul 17, 2001 |
| Priority date | — |
| Expiry date | Dec 31, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16322
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention is in the field of lymphadenopathy virus, which has been designated Human Immunodeficiency Virus Type 1 (HIV-1). This invention relates to a diagnostic means and method to detect the presence of DNA, RNA or antibodies of the lymphadenopathy retrovirus associated with the acquired immune deficiency syndrome or of the lymphadenopathy syndrome by the use of DNA fragments or the peptides encoded by said DNA fragments. The invention further relates to the DNA fragments, vectors comprising them and the proteins expressed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.